Cargando…
Simvastatin protects high glucose-induced H9c2 cells from injury by inducing autophagy
CONTEXT: Simvastatin is the first line therapeutic drug for coronary heart disease and atherosclerosis. The protective effect mechanism of simvastatin on cardiomyocytes is unclear. OBJECTIVE: This study explores the effect of simvastatin on high glucose induced cardiomyocyte injury and the role of a...
Autores principales: | E, Lusha, Jiang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655079/ https://www.ncbi.nlm.nih.gov/pubmed/33164619 http://dx.doi.org/10.1080/13880209.2020.1839512 |
Ejemplares similares
-
Alterations in necroptosis during ALDH2-mediated protection against high glucose-induced H9c2 cardiac cell injury
por: Fang, Tingting, et al.
Publicado: (2018) -
Simvastatin Protects Heart from Pressure Overload Injury by Inhibiting Excessive Autophagy
por: Su, Feifei, et al.
Publicado: (2018) -
Silencing of PFKFB3 protects podocytes against high glucose-induced injury by inducing autophagy
por: Zhu, Zhengming, et al.
Publicado: (2021) -
Neuroprotective Effect of Simvastatin via Inducing the Autophagy on Spinal Cord Injury in the Rat Model
por: Gao, Kai, et al.
Publicado: (2015) -
Proteomics Research on the Protective Effect of Mangiferin on H9C2 Cell Injury Induced by H(2)O(2)
por: Guan, Wei, et al.
Publicado: (2019)